Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

How new diagnostic pathways can support earlier diagnosis and appropriate management in patients with lower gastrointestinal ...

I had a symptom of colon cancer and family history, so I got a colonoscopy. It was expensive, and insurance was a nightmare, ...

Dr Ray O’Connor takes a look at the latest clinical articles on gastrointestinal cancers – which comprise more than ...

Appendix cancer is a rare but increasingly recognized malignancy, often discovered incidentally during surgery for presumed ...

Cancer patients receiving immune checkpoint inhibitor (ICI) therapy may experience more severe toxicity and have a greater risk of death if they have recently used proton pump inhibitors (PPIs), ...

Though extremely rare, cancers of the appendix are being diagnosed at higher rates in Gen X and millennials compared with earlier cohorts.

BE is the only known precursor to esophageal cancer. The condition is caused by prolonged exposure of the esophagus to ...

Three of five patients with advanced colorectal cancer responded to leronlimab, including one complete response lasting five years, according to new data.

Although cancer of the appendix is rare — typically, it's estimated to affect about 1 or 2 people for every 1 million in the United States each year — diagnoses are rising sharply among Generation X ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Cathey Chustz, a lifelong Baton Rouge local, has been married 44 years and has two grown daughters and two young grandchildren. In her career, she worked for the state’s highway department and later ...